An in situ cross-linking hybrid hydrogel for controlled release of proteins

Acta Biomaterialia

Volumn 8, Issue 5, 2012, Pages 1703-1709

  Epstein Barash, Hila ^a,b   Stefanescu, Cristina F ^a   Kohane, Daniel S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

Controlled release; Drug delivery; Gelatin; Hydrogel; Protein

Indexed keywords

CONTROLLED DRUG DELIVERY; CROSSLINKING; GELATION; HYALURONIC ACID; HYDROGELS; PROTEINS; TARGETED DRUG DELIVERY;

CARBOXYMETHYL CELLULOSE; CONTROLLED RELEASE; GELATIN; HYBRID HYDROGELS; INTERLEUKIN2 (IL2); PROTEIN CONCENTRATIONS; PROTEIN DELIVERY SYSTEMS; SITU CROSS-LINKING; SYSTEMIC DELIVERIES; THERAPEUTIC PROTEIN;

DEXTRAN;

ALBUMIN; CARBOXYMETHYLCELLULOSE; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; GELATIN; HYALURONIC ACID; INTERLEUKIN 2; ORGANIC SOLVENT; POLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; CROSS LINKING; CYTOTOXICITY; GELATION; HUMAN; HUMAN CELL; HYDROGEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

RATTUS;

EID: 84859103023     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2012.01.028     Document Type: Article

References (24)

1. S. Cohen, T. Yoshioka, M. Lucarelli, L.H. Hwang, and R. Langer Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres Pharm Res 8 1991 713 720
2. Y. Ikada, and Y. Tabata Protein release from gelatin matrices Adv Drug Deliv Rev 31 1998 287 301
3. S. Hautmann, E. Huland, A. Wullbrand, M. Friedrich, and H. Huland Treatment of metastatic hormone-refractory prostate adenocarcinoma (MatLyLu) in Copenhagen rats with micro-osmotic interleukin-2 pumps Anticancer Res 20 2000 4495 4498
4. H. Lorberboum-Galski, R. Lafyatis, J.P. Case, D. FitzGerald, R.L. Wilder, and I. Pastan Administration of IL-2-PE40 via osmotic pumps prevents adjuvant induced arthritis in rats. Improved therapeutic index of IL-2-PE40 administered by continuous infusion Int J Immunopharmacol 13 1991 305 315
5. J.M. Barichello, M. Morishita, K. Takayama, and T. Nagai Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats Int J Pharm 184 1999 189 198
6. Z.S. Patel, M. Yamamoto, H. Ueda, Y. Tabata, and A.G. Mikos Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2 Acta Biomaterialia 4 2008 1126 1138
7. M.S. Hahn, B.A. Teply, M.M. Stevens, S.M. Zeitels, and R. Langer Collagen composite hydrogels for vocal fold lamina propria restoration Biomaterials 27 2006 1104 1109
8. J. Riesle, A.P. Hollander, R. Langer, L.E. Freed, and G. Vunjak-Novakovic Collagen in tissue-engineered cartilage: types, structure, and crosslinks J Cell Biochem 71 1998 313 327
9. N.K. Egilmez, Y.S. Jong, Y. Iwanuma, J.S. Jacob, C.A. Santos, and F.A. Chen Cytokine immunotherapy of cancer with controlled release biodegradable microspheres in a human tumor xenograft/SCID mouse model Cancer Immunol Immunother 46 1998 21 24
10. Y. Tabata, A. Nagano, and Y. Ikada Biodegradation of hydrogel carrier incorporating fibroblast growth factor Tissue Eng 5 1999 127 138
11. D.S. Kohane, J.Y. Tse, Y. Yeo, R. Padera, M. Shubina, and R. Langer Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum J Biomed Mater Res A 77 2006 351 361
12. T.R. Hoare, and D.S. Kohane Hydrogels in drug delivery: progress and challenges Polymer 49 2008 1993 2007
13. Y. Yeo, and D.S. Kohane Polymers in the prevention of peritoneal adhesions Eur J Pharm Biopharm 68 2008 57 66
14. Y. Tabata, and Y. Ikada Synthesis of gelatin microspheres containing interferon Pharm Res 6 1989 422 427
15. Y. Tabata, Y. Ikada, K. Morimoto, H. Katsumata, T. Yabuta, and K. Iwanaga Surfactant-free preparation of biodegradable hydrogel microspheres for protein release J Bioact Compat Polym 14 1999 371 384
16. Y. Yeo, M. Adil, E. Bellas, A. Astashkina, N. Chaudhary, and D.S. Kohane Prevention of peritoneal adhesions with an in situ cross-linkable hyaluronan hydrogel delivering budesonide J Control Release 120 2007 178 185
17. P. Bulpitt, and D. Aeschlimann New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels J Biomed Mater Res 47 1999 152 169
18. Y. Yeo, C.B. Highley, E. Bellas, T. Ito, R. Marini, and R. Langer In situ cross-linkable hyaluronic acid hydrogels prevent post-operative abdominal adhesions in a rabbit model Biomaterials 27 2006 4698 4705
19. Y. Yeo, E. Bellas, C.B. Highley, R. Langer, and D.S. Kohane Peritoneal adhesion prevention with an in situ cross-linkable hyaluronan gel containing tissue-type plasminogen activator in a rabbit repeated-injury model Biomaterials 28 2007 3704 3713
20. T. Ito, Y. Yeo, C.B. Highley, E. Bellas, C.A. Benitez, and D.S. Kohane The prevention of peritoneal adhesions by in situ cross-linking hydrogels of hyaluronic acid and cellulose derivatives Biomaterials 28 2007 975 983
21. T. Ito, Y. Yeo, C.B. Highley, E. Bellas, and D.S. Kohane Dextran-based in situ cross-linked injectable hydrogels to prevent peritoneal adhesions Biomaterials 28 2007 3418 3426
22. Y. Yeo, T. Ito, E. Bellas, C.B. Highley, R. Marini, and D.S. Kohane In situ cross-linkable hyaluronan hydrogels containing polymeric nanoparticles for preventing postsurgical adhesions Ann Surg 245 2007 819 824
23. U. Hammerling, A.C. Henningsson, and L. Sjodin Development and validation of a bioassay for interleukin-2 J Pharm Biomed Anal 10 1992 547 553
24. H. Epstein-Barash, G. Orbey, B.E. Polat, R.H. Ewoldt, J. Feshitan, and R. Langer A microcomposite hydrogel for repeated on-demand ultrasound-triggered drug delivery Biomaterials 31 2010 5208 5217